According to the announcement from Shanghai Pharmaceuticals Holding Co., Ltd. (02607), a resolution passed on 11 February 2026 elected Mr. Zhao Yong, aged 53, as the employee Director of the eighth session of its Board. His term of office will run from the date of this employee representative meeting until the expiry of the current Board session. The newly elected Director holds a master’s degree in Laws from Fudan University and completed advanced business administration studies at Cheung Kong Graduate School of Business. Currently, he serves as deputy secretary to the Party Committee, vice president of Shanghai Pharmaceuticals Holding Co., Ltd., and director of several subsidiaries.
Mr. Zhao previously held roles as vice president at Shanghai Labway Clinical Laboratory Co., Ltd. (stock code: 301060), among other positions with the Shanghai Municipal Health and Family Planning Commission and Shanghai Changning District authorities. He does not hold any equity interest in Shanghai Pharmaceuticals Holding Co., Ltd. and has no relationship with other Directors, senior management, or major shareholders. There is no director’s service contract between Mr. Zhao and the company, and he will receive remuneration according to the company’s internal system rather than a specific director’s salary. No information subject to disclosure requirements under the Listing Rules was omitted, and there are no other matters requiring additional shareholder attention.
Comments